propylparaben has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Haza'a, A; Bowen, ID; Brennan, P; Buggins, AG; Fegan, C; Hewamana, S; Lin, TT; Mahdi, AJ; Mahdi, E; Mahdi, JG; Morgan, L; Pearce, L; Pepper, C; Walsby, E | 1 |
1 other study(ies) available for propylparaben and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2.
Topics: ADP-ribosyl Cyclase 1; Aged; Animals; Antineoplastic Agents; Apoptosis; Aspirin; Caspase 3; Caspase Inhibitors; CD40 Antigens; Coculture Techniques; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Membrane Glycoproteins; Mice; Oligopeptides; Parabens; Salicylic Acid; Transcription Factor RelA; Transcription, Genetic; Tumor Cells, Cultured; ZAP-70 Protein-Tyrosine Kinase | 2011 |